Key result
Cardiovascular magnetic resonance imaging provides a comprehensive assessment of myocardial function, perfusion, and viability to guide the diagnosis and management of ischemic cardiomyopathy.
Why the study?
What is the role of cardiovascular magnetic resonance imaging in the diagnosis, prognosis, and management of ischemic cardiomyopathy?
What is the role of cardiovascular magnetic resonance imaging in the diagnosis, prognosis, and management of ischemic cardiomyopathy?
This review highlights the comprehensive utility of CMR in diagnosing, risk-stratifying, and guiding revascularization decisions in patients with ischemic cardiomyopathy.
May inform ischemic cardiomyopathy evaluation; leaves open need for prospective outcome trials.
Coronary artery disease (CAD) represents an important cause of mortality. Cardiovascular magnetic resonance (CMR) imaging evolved as an imaging modality that allows the assessment of myocardial function, perfusion, contractile reserve and extent of fibrosis in a single comprehensive exam. This review highlights the role of CMR in the differential diagnosis of acute chest pain by detecting the location of obstructive CAD or necrosis and identifying other conditions like stress cardiomyopathy or myocarditis that can present with acute chest pain. Besides, it underlines the prognostic implication of perfusion abnormalities in the setting of acute chest pain. Furthermore, the review addresses the role of CMR to detect significant CAD in patients with stable CAD. It elucidates the accuracy and clinical utility of CMR with respect to other imaging modalities like single-photon emission computed tomography and positron emission tomography. Besides, the prognostic value of CMR stress testing is discussed. Additionally, it summarizes the available CMR techniques to assess myocardial viability and describes algorithm to identify those patient who might profit from revascularization those who should be treated medically. Finally, future promising imaging techniques that will provide further insights into the fundamental disease processes in ischemic cardiomyopathy are discussed.
No takes yet. Share an insight, caveat, or question.
Christina Doesch (2014) conducted a review in Ischemic cardiomyopathy. Cardiovascular magnetic resonance (CMR) imaging vs. Single-photon emission computed tomography and positron emission tomography was evaluated. Cardiovascular magnetic resonance imaging provides a comprehensive assessment of myocardial function, perfusion, and viability to guide the diagnosis and management of ischemic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: